These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 10560952

  • 1. A T2S cross-reactive material (compound W) in hyperthyroid patients with trophoblastic disease.
    Rajatanavin R, Fisher DA, Chailurkit L, Huang WS, Srisupandit S, Wu SY.
    Thyroid; 1999 Oct; 9(10):989-94. PubMed ID: 10560952
    [Abstract] [Full Text] [Related]

  • 2. A 3,3'-diiodothyronine sulfate cross-reactive compound in serum from pregnant women.
    Wu SY, Polk DH, Chen WL, Fisher DA, Huang WS, Yee B.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1505-9. PubMed ID: 8200954
    [Abstract] [Full Text] [Related]

  • 3. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary.
    Kato K, Mostafa MH, Mann K, Schindler AE, Hoermann R.
    Gynecol Endocrinol; 2004 May; 18(5):269-77. PubMed ID: 15346663
    [Abstract] [Full Text] [Related]

  • 4. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations.
    Lockwood CM, Grenache DG, Gronowski AM.
    Thyroid; 2009 Aug; 19(8):863-8. PubMed ID: 19505185
    [Abstract] [Full Text] [Related]

  • 5. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole.
    Amir SM, Osathanondh R, Berkowitz RS, Goldstein DP.
    Am J Obstet Gynecol; 1984 Nov 15; 150(6):723-8. PubMed ID: 6496594
    [Abstract] [Full Text] [Related]

  • 6. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 15; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 7. Thromboblastic hyperthyroidism: sensitive monoclonal TSH assay demonstrates suppressed immunoreactive TSH.
    Abuaisha B, Barrett E, O'Hare J.
    Ir J Med Sci; 1991 Mar 15; 160(3):96-7. PubMed ID: 1917429
    [Abstract] [Full Text] [Related]

  • 8. Maternal compound W serial measurements for the management of fetal hypothyroidsm.
    Cortelazzi D, Morpurgo PS, Zamperini P, Fisher DA, Beck-Peccoz P, Wu SY.
    Eur J Endocrinol; 1999 Dec 15; 141(6):570-8. PubMed ID: 10601958
    [Abstract] [Full Text] [Related]

  • 9. Thyroid function and human chorionic gonadotropin in patients with hydatidiform mole.
    Ngowngarmratana S, Sunthornthepvarakul T, Kanchanawat S.
    J Med Assoc Thai; 1997 Nov 15; 80(11):693-9. PubMed ID: 9385765
    [Abstract] [Full Text] [Related]

  • 10. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec 15; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 11. [Serum TSH levels in normal pregnant women and patients with hydatidiform mole and influence of HCG on TSH immunoradiometric assay].
    Hara H, Ban Y, Sato R, Nagakura H, Kushima K, Kaihara M, Matsuzaki H.
    Kaku Igaku; 1988 Jan 15; 25(1):89-96. PubMed ID: 3373811
    [No Abstract] [Full Text] [Related]

  • 12. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul 15; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 15; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 16. Thyroid function in molar pregnancy.
    Nagataki S, Mizuno M, Sakamoto S, Irie M, Shizume K.
    J Clin Endocrinol Metab; 1977 Feb 15; 44(2):254-63. PubMed ID: 402378
    [Abstract] [Full Text] [Related]

  • 17. Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors.
    Hershman JM.
    Thyroid; 1999 Jul 15; 9(7):653-7. PubMed ID: 10447009
    [Abstract] [Full Text] [Related]

  • 18. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct 15; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 19. Clinical comparison of immunoradiometric assays for intact versus beta-specific human chorionic gonadotropin.
    Pardue MG, Taylor EH, London S, Walls RC, Pappas AA.
    Am J Clin Pathol; 1990 Mar 15; 93(3):347-51. PubMed ID: 1689940
    [Abstract] [Full Text] [Related]

  • 20. Compound W, a 3,3'-diiodothyronine sulfate cross-reactive substance in serum from pregnant women--a potential marker for fetal thyroid function.
    Wu SY, Huang WS, Ho E, Wu ES, Fisher DA.
    Pediatr Res; 2007 Mar 15; 61(3):307-12. PubMed ID: 17314688
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.